Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Squirrell

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
The British Journal of Ophthalmology|December 4, 2018
Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real-world outcomes at 24 monthsAlessandro Invernizzi, Kelvin Teo, Vuong Nguyen, et al.
Journal of Anatomy|May 24, 2023
Hyper-reflective dots in optical coherence tomography imaging and inflammation markers in diabetic retinopathyMohd N Mat Nor, Cindy X Guo, Colin R Green, et al.
Eye (London, England)|September 3, 2022
A multi-centre prospective evaluation of THEIA™ to detect diabetic retinopathy (DR) and diabetic macular oedema (DMO) in the New Zealand screening programEhsan Vaghefi, Song Yang, Li Xie, et al.
Clinical & Experimental Ophthalmology|December 31, 2019
Outcomes of cataract surgery in eyes with diabetic macular oedema: Data from the Fight Retinal Blindness! RegistrySanjeeb Bhandari, Anne C Biechl, Vuong Nguyen, et al.
American Journal of Ophthalmology|October 14, 2019
Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two RegionsMark Gillies, Jennifer Arnold, Sanjeeb Bhandari, et al.
Clinical & Experimental Ophthalmology|July 23, 2022
One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusionNancy Wang, Adrian Hunt, Vuong Nguyen, et al.
Clinical & Experimental Ophthalmology|June 15, 2021
Neovascular age-related macular degeneration at treatment intervals of 14 weeks or greaterElisa E Cornish, Vuong Nguyen, Stephanie Young, et al.
The New Zealand Medical Journal|June 25, 2026
Interrupted diabetes eye care in Te Toka Tumai Auckland 2008-2019: analysis of routinely collected health-facility dataPushkar R Silwal, Maryam Pirouzi, Arier Lee, et al.
Retina (Philadelphia, Pa.)|March 2, 2019
ASSESSING THE ACCURACY OF A LARGE OBSERVATIONAL REGISTRY OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONVuong Nguyen, King Fai Calvin Leung, Chu Luan Nguyen, et al.
Eye (London, England)|March 26, 2021
Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! RegistrySanjeeb Bhandari, David Squirrell, Vuong Nguyen, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
The British Journal of Ophthalmology|December 4, 2018
Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular endothelial growth factor: real-world outcomes at 24 monthsAlessandro Invernizzi, Kelvin Teo, Vuong Nguyen, et al.
Journal of Anatomy|May 24, 2023
Hyper-reflective dots in optical coherence tomography imaging and inflammation markers in diabetic retinopathyMohd N Mat Nor, Cindy X Guo, Colin R Green, et al.
Eye (London, England)|September 3, 2022
A multi-centre prospective evaluation of THEIA™ to detect diabetic retinopathy (DR) and diabetic macular oedema (DMO) in the New Zealand screening programEhsan Vaghefi, Song Yang, Li Xie, et al.
Clinical & Experimental Ophthalmology|December 31, 2019
Outcomes of cataract surgery in eyes with diabetic macular oedema: Data from the Fight Retinal Blindness! RegistrySanjeeb Bhandari, Anne C Biechl, Vuong Nguyen, et al.
American Journal of Ophthalmology|October 14, 2019
Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two RegionsMark Gillies, Jennifer Arnold, Sanjeeb Bhandari, et al.
Clinical & Experimental Ophthalmology|July 23, 2022
One-year real-world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusionNancy Wang, Adrian Hunt, Vuong Nguyen, et al.
Clinical & Experimental Ophthalmology|June 15, 2021
Neovascular age-related macular degeneration at treatment intervals of 14 weeks or greaterElisa E Cornish, Vuong Nguyen, Stephanie Young, et al.
The New Zealand Medical Journal|June 25, 2026
Interrupted diabetes eye care in Te Toka Tumai Auckland 2008-2019: analysis of routinely collected health-facility dataPushkar R Silwal, Maryam Pirouzi, Arier Lee, et al.
Retina (Philadelphia, Pa.)|March 2, 2019
ASSESSING THE ACCURACY OF A LARGE OBSERVATIONAL REGISTRY OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONVuong Nguyen, King Fai Calvin Leung, Chu Luan Nguyen, et al.
Eye (London, England)|March 26, 2021
Bevacizumab for diabetic macular oedema: one-year treatment outcomes from the Fight Retinal Blindness! RegistrySanjeeb Bhandari, David Squirrell, Vuong Nguyen, et al.
Pageof 4